Handbook of Drug Monitoring Methods

Therapeutics and Drugs of Abuse
 Gb
Sofort lieferbar | Lieferzeit:3-5 Tage I
ISBN-13:
9781588297808
Einband:
Gb
Erscheinungsdatum:
01.11.2007
Seiten:
446
Autor:
Amitava Dasgupta
Gewicht:
1060 g
Format:
263x184x29 mm
Sprache:
Englisch
Beschreibung:

In this handbook, the authors discuss the different analytical techniques used in today's practice of therapeutic drug monitoring and drugs of abuse as well as alcohol testing. The volume's first half focuses on various issues of therapeutic drug monitoring. Additional chapters cover analysis of heavy metals, alcohol testing, and issues of drugs of abuse testing. These chapters are written by experts in their relative sub-specialties and also by the editor.
Content

1. Chapter 1: Introduction to Therapeutic Drug Monitoring. Amitava Dasgupta, Ph.D. Department of Pathology and Laboratory Medicine, University of Texas-Houston, Medical School, Houston, TX

2. Chapter 2. Monitoring Free Drug Concentration. Amitava Dasgupta, Ph.D. Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, Houston, TX.

3. Chapter 3. Analytical Techniques for Measuring Concentrations of Therapeutic Drugs in Biological Fluids. Amitava Dasgupta and Pradip Datta. Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, Houston, Texas and Bayer HealthCare, Diagnostics Division, Tarrytown, NY

4. Chapter 4. The Pre-Analytical Phase of Drug Testing: From Specimen Collection to Analysis. Catherine A. Hammett-Stabler, Ph.D. Department of Pathology and Laboratory Medicine University of North Carolina at Chapel Hill

5. Chapter 5. Effect of Hemolysis, High Bilirubin, Lipemia, Paraproteins and System Factors on Therapeutic Drug Monitoring. Pradip Datta, PhD. Bayer HealthCare, Diagnostics Division, Tarrytown, NY

6. Chapter 6: Digoxin: So Many Interferences and How to Eliminate Them. Amitava Dasgupta, Ph.D. Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, Houston, TX
7. Chapter 7. Interferences with Measurement of Anticonvulsants. William Clarke, Ph.D. Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland

8. Chapter 8. Pitfalls in Measuring Antidepressant Drugs. Uttam Garg, Ph.D. Department of Pathology and Laboratory Medicine University of Missouri, Kansas City and Children's Mercy Hospitals and Clinics, Kansas City, MO.

9. Chapter 9. Immunosuppressive Drugs: Pharmacokinetics, Preanalytic Variables, and Analytical Considerations. Anthony W. Butch, Ph.D. Department of Pathology and Laboratory Medicine, Geffen School of Medicine, University of California at Los Angeles, Los Angeles, CA 90095-1732

10. Chapter 10. Therapeutic Drug Monitoring in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Steven J Soldin PhD. Department of Pharmacology, Georgetown University and Department of Laboratory Medicine, Children's National Medical Center

11. Chapter 11. Pharmacogenomics and Personalized Medicine: Issues and Methodology. Steven H. Y. Wong. Department of Pathology, Medical College of Wisconsin And Toxicology Department, Milwaukee County Medical Examiner's Office, Milwaukee, WI,

12. Chapter 12. Interference of Heterophilic and Other Antibodies in Measurement of Therapeutic Drugs by Immunoassays. Pradip Datta, PhD. Bayer HealthCare, Diagnostics Division, Tarrytown, NY

13. Chapter 13. Drug-Herb and Drug-Food Interactions: Impact on Therapeutic Drug Monitoring. Amitava Dasgupta, Ph.D Department of Pathology and Laboratory Medicine, University of Texas-Houston Medical School, Houston, TX

14. Chapter 14. Toxic Element Testing with Clinical Specimens. Gwendolyn A. McMillin, Ph.D.1,2 and Joshua A. Bornhorst, Ph.D. 3 1 ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah, 2 Department of Pathology, University of Utah, Salt Lake City, Utah 84132, 3 Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR

15. Chapter 15. Alcohol Testing. Steve C. Kazmierczak, Ph.D and Hassan ME Azzazy, Ph.D. Department of Pathology, Oregon Health & Science University, Portland, Oregon and Department of Chemistry, The American University of Cairo, Egypt

16. Chapter 16. Introduction to Drugs of Abuse Testing. Tai C. Kwong, Ph.D. Department of Pathology, University of Rochester Medical Center, Rochester, NY

17. Chapter 17. Urinary
In Handbook of Drug Monitoring Methods: Therapeutics and Drug Abuse, authors discuss the different analytical techniques used in today s practice of therapeutic drug monitoring and drugs of abuse as well as alcohol testing with relevant theory, mechanism, and in-depth scientific discussion on each topic. This volume is the perfect handbook and quick reference for any clinical laboratory, allowing clinicians to find the potential source of a false-positive or a false-negative result in the daily operation of a toxicology laboratory. At the same time, this book can also be used as a reference for medical technologists, supervisors, laboratory directors, clinical chemists, toxicologists, and pathologists to find in-depth cause of a potential interference and what tests can be ordered to circumvent such problem. The volume s first half focuses on various issues of therapeutic drug monitoring. Additional chapters cover analysis of heavy metals, alcohol testing, and issues of drugs of abuse testing. These chapters are written by experts in their relative sub-specialties and also by the editor. Comprehensive and timely, Handbook of Drug Monitoring Methods: Therapeutics and Drug Abuse is the ideal text for clinicians and researchers monitoring alcohol and drug testing and other important tasks of toxicological laboratory services.

Kunden Rezensionen

Zu diesem Artikel ist noch keine Rezension vorhanden.
Helfen sie anderen Besuchern und verfassen Sie selbst eine Rezension.